COVIRIC: Durability of protective immune responses triggered by primary SARS-CoV-2 infection in patients with rheumatoid arthritis or spondyloarthritis - Impact of immunosuppressive treatments.

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$0
Funder
ANR
Principal Investigator
Corinne Miceli
Research Location
France
Lead Research Institution
Hôpitaux de Paris Groupe Hospitalier Cochin Saint-Vincent-de-Paul / Paris
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

The COVIRIC project, coordinated by Corinne Miceli (Assistance Publique - Hôpitaux de Paris Groupe Hospitalier Cochin Saint-Vincent-de-Paul / Paris), aims to study the impact of immunosuppressive treatments on viral load and humoral and cellular responses during a viral infection with SARS-CoV-2, in patients with rheumatoid arthritis or spondyloarthritis, compared to other members of the infected family group.